Immunosenescence Correlates with Poor Outcome from PD-(L)1 Blockade but Not Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)

被引：0

作者：

Ferrara, R. ^{[1
]}

Naigeon, M. ^{[2
]}

Auclin, E. ^{[3
]}

Duchemann, B. ^{[2
]}

Cassard, L. ^{[2
]}

Medhi, J. J. ^{[2
]}

Boselli, L. ^{[2
]}

Grivel, J. ^{[2
]}

Desnoyer, A. ^{[2
]}

Texier, M. ^{[2
]}

Mezquita, L. ^{[2
]}

Aboubakar, F. ^{[2
]}

Hendriks, L. ^{[4
]}

Planchard, D. ^{[2
]}

Caramella, C. ^{[5
]}

Remon, J. ^{[6
]}

Ngocamus, M. ^{[2
]}

Nicotra, C. ^{[2
]}

Proto, C. ^{[1
]}

Sangaletti, S. ^{[7
]}

Chaput, N. ^{[2
]}

Besse, B. ^{[2
]}

机构：

[1] Fdn Irccs Ist Nazl Tumori Milan, Thorac Oncol Unit, Milan, Italy

[2] Gustave Roussy, Villejuif, France

[3] Hop Europeen Georges Pompidou, Paris, France

[4] Gustave Roussy, Oncol, Villejuif, France

[5] Gustave Roussy Canc Campus, Dept Radiol, Villejuif, France

[6] Hosp Hm Delfos, Barcelona, Spain

[7] Fdn Irccs Ist Nazl Tumori, Milan, Italy

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期

关键词：

Immunecheckpoint blockade; immunosenescence; NSCLC;

D O I：

10.1016/j.jtho.2019.08.934

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.04-31

引用

页码：S452 / S452

页数：1

共 50 条

[21] CHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER (NSCLC)
KLASTERSKY, J
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (07): : 1035 - 1038
[22] Chemotherapy for advanced non-small cell lung cancer (NSCLC)
Manegold, C
LUNG CANCER, 2002, 38 : S47 - S50
[23] Adjuvant chemotherapy in non-small cell lung cancer (NSCLC)
Felip, E.
Cedres, S.
Peralta, S.
Prat, A.
ANNALS OF ONCOLOGY, 2007, 18 : 143 - 146
[24] CHEMOTHERAPY FOR NON-SMALL CELL LUNG-CANCER (NSCLC)
THATCHER, N
BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 886 - 887
[25] Sequential chemotherapy in non-small cell lung cancer (NSCLC)
不详
ANTICANCER RESEARCH, 2005, 25 (6D) : 4831 - 4832
[26] Impact of STK11 copy loss on clinical outcomes to PD-(L)1 blockade in non-small cell lung cancer.
Gutierrez, Catherine
Ricciuti, Biagio
Alessi, Joao Victor Machado
Pecci, Federica
De Castro Barrichello, Adriana Paula
Vaz, Victor R.
Sholl, Lynette M.
Awad, Mark M.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[27] Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer
Ricciuti, Biagio
Lamberti, Giuseppe
Puchala, Sreekar R.
Mahadevan, Navin R.
Lin, Jia-Ren
Alessi, Joao V.
Chowdhury, Alexander
Li, Yvonne Y.
Wang, Xinan
Spurr, Liam
Pecci, Federica
Di Federico, Alessandro
Venkatraman, Deepti
Barrichello, Adriana P.
Gandhi, Malini
Vaz, Victor R.
Pangilinan, Andy J.
Haradon, Danielle
Lee, Elinton
Gupta, Hersh
Pfaff, Kathleen L.
Welsh, Emma L.
Nishino, Mizuki
Cherniack, Andrew D.
Johnson, Bruce E.
Weirather, Jason L.
Dryg, Ian D.
Rodig, Scott J.
Sholl, Lynette M.
Sorger, Peter
Santagata, Sandro
Umeton, Renato
Awad, Mark M.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (11) : 1311 - 1321
[28] PD-L1-Gene Expression by nCounter Correlates with PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)
Cabrera, C.
Aguado, C.
Teixido, C.
Pare, L.
Castellvi, J.
Lopez, L.
Marin, E.
Bernal, X.
Martinez, D.
Gimenez-Capitan, A.
Vinolas, N.
Yeste, Z.
Baixeras, N.
Roman, R.
Molina-Vila, M.
Reguart, N.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S927 - S927
[29] Efficacy and safety of the PD-1/PD-L1 in metastasic non-small cell lung cancer (NSCLC)
Gonzalez-Velez, Abel
Pino-Villareal, Luis E.
Barrera-Barinas, Alexander
Castillo-Niuman, Andrea
Tolosa-Perez, Erica N.
Castelblanco, Diana, I
Pinzon-Florez, Carlos E.
Yomayusa, Nancy
GACETA MEXICANA DE ONCOLOGIA, 2021, 20 (03): : 111 - 123
[30] Prognostic impact of the use of antibiotics in patients with advanced non-small cell lung cancer (NSCLC) receiving PD-(L)1 targeting monoclonal antibodies
Schett, A.
Rothschild, S. I.
Mauti, L. A.
Schmid, S.
Appenzeller, C.
Curioni-Fontecedro, A.
Frueh, M.
Joerger, M.
ANNALS OF ONCOLOGY, 2019, 30 : 58 - 58

← 1 2 3 4 5 →